Multipeptide vaccine (Eberhard-Karls-Universitaet Tuebingen)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameMultipeptide vaccine (Eberhard-Karls-Universitaet Tuebingen)
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGerman Consortium For Translational Cancer ResearchEberhard-Karls Universitaet Tuebingen
China Registration ClassN/A

Develop Information

Active CompaniesGerman Consortium For Translational Cancer ResearchEberhard-Karls Universitaet Tuebingen
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A